小檗碱
化学
急性毒性
毒性
药理学
促炎细胞因子
细胞培养
生物碱
衍生工具(金融)
细胞
癌症
细胞生长
肺癌
药品
癌细胞系
细胞凋亡
细胞毒性
癌细胞
程序性细胞死亡
半数致死剂量
中医药
作者
Ren‐Tao Zhang,Qi‐Qi Xie,Xiao‐Long Sun,Yi‐Ling Xie,Tianyu Zhang,Shuo Li,Yu‐Ting Wu,Xiang‐Yu Jin,Bin‐Ying Wang,Xuan Cao,Danqing Song,Chun‐Lian Ma,Xiaodan Wang,Ling‐Fu Chen,Ming Tan,Tianyun Fan,Qiong-Ying Hu
标识
DOI:10.1002/cbdv.202501981
摘要
ABSTRACT Berberine (BBR) is a traditional Chinese medicine which has been extensively utilized in treating various diseases. By cyclizing the 8‐ and 9‐positions of berberine, a novel derivative, 2,3‐dimethyldioxy‐9‐methyl‐11‐methoxy‐8,10‐cycloberberine chloride ( BN‐7 ), was synthesized for the first time. Its anticancer and anti‐inflammatory activities, as well as acute toxicity profile, were also evaluated. BN‐7 demonstrated potent antiproliferative activity, effectively suppressing the growth of two non–small cell lung cancer (NSCLC) cell lines through paraptosis. It also significantly inhibited the production of proinflammatory cytokines in LPS‐stimulated RAW264.7 and THP‐1 cells. Furthermore, acute toxicity studies following intravenous administration revealed that the median lethal dose (LD 50 ) of BN‐7 was 7.42 mg/kg (95% CI: 6.09–9.15) in Institute of Cancer Research (ICR) mice; and 11.82 mg/kg (95% CI: 9.80–14.43) in Sprague Dawley (SD) rats. No significant changes were found in mortality, behavior, body weight, organ coefficients, or pathological observation at the dose of 5.25 mg/kg. Therefore, our findings provide novel insights into BN‐7 , indicating its potential as an anticancer and anti‐inflammatory agent.
科研通智能强力驱动
Strongly Powered by AbleSci AI